| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
2 companies
Nissenson Allen is a Director at RMTI with holdings across 2 companies. Recent SEC Form 4 filings include 2 buys and 0 sells.
Estimated insider holdings value: $208K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 20, 2022 | ELTX Elicio Therapeutics, Inc. | Director | Buy | 9,383 | $1.16 | $10,925.02 | +127.7% | -20.3% | -38.3% |